Evidence map›Paper›PMID 32005928›Full record

ArticleScientific reports2020

Downregulation of testosterone production through luteinizing hormone receptor regulation in male rats exposed to 17α-ethynylestradiol.

Po-Han Lin, Tsung-Hsien Kuo, Chih-Chieh Chen, Cai-Yun Jian, Chien-Wei Chen, Kai-Lee Wang, Yuh-Chen Kuo, Heng-Yi Shen, Shih-Min Hsia, Paulus S Wang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Endocrine Disrupting Agents: Toxicological Aspects on Male Reproduction.Reproductive sciences (Thousand Oaks, Calif.) · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Po-Han LinInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Tsung-Hsien KuoInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Chih-Chieh ChenInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Cai-Yun JianInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Chien-Wei ChenInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Kai-Lee WangInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan.
Yuh-Chen KuoDepartment of Urology, Yangming Branch of Taipei City Hospital, Taipei, 11146, Taiwan.
Heng-Yi ShenDepartment of Rehabilitation, Cheng Hsin General Hospital, Taipei, 11212, Taiwan.
Shih-Min HsiaSchool of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei, 11031, Taiwan.
Paulus S WangInstitute and Department of Physiology, School of Medicine, National Yang-Ming University, Taipei, 11221, Taiwan. pswang3879@gmail.com.
Fu-Kong LieuDepartment of Rehabilitation, Cheng Hsin General Hospital, Taipei, 11212, Taiwan. ch2276@chgh.org.tw.
Shyi-Wu WangAesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, 33378, Taiwan. swwang@mail.cgu.edu.tw.
National Yang Ming Chiao Tung University · TWCheng Hsin General Hospital · TWChang Gung Memorial Hospital · TWNational Taipei University of Nursing and Health Science · TWTaipei City Hospital · TWTaipei Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmaceutical 17α-ethynylestradiol (EE2) is considered as an endocrine-disrupting chemical that interferes with male reproduction and hormonal activation. In this study, we investigated the molecular mechanism underlying EE2-regulatory testosterone release in vitro and in vivo. The results show that EE2 treatment decreased testosterone release from rat Leydig cells. Treatment of rats with EE2 reduced plasma testosterone levels and decreased the sensitivity of human chorionic gonadotropin (hCG). EE2 reduced luteinizing hormone receptor (LHR) expression associated with decreased cAMP generation by downregulation of adenylyl cyclase activity and decreased intracellular calcium-mediated pathways. The expression levels of StAR and P450scc were decreased in Leydig cells by treatment of rats with EE2 for 7 days. The sperm motility in the vas deferens and epididymis was reduced, but the histopathological features of the testis and the total sperm number of the vas deferens were not affected. Moreover, the serum dihydrotestosterone (DHT) level was decreased by treatment with EE2. The prostate gland and seminal vesicle atrophied significantly, and their expression level of 5α-reductase type II was reduced after EE2 exposure. Taken together, these results demonstrate an underlying mechanism of EE2 to downregulate testosterone production in Leydig cells, explaining the damaging effects of EE2 on male reproduction.

Indexed as

Adenylyl CyclasesAnimalsChorionic GonadotropinColforsinCyclic AMPDown-RegulationEthinyl EstradiolLeydig CellsMaleRatsRats, Sprague-DawleyReceptors, LHTestosteroneAdenylyl CyclasesChorionic GonadotropinColforsinCyclic AMPEthinyl EstradiolReceptors, LHTestosterone

Identifiers

PMID32005928
PMCPMC6994641
OpenAlexW3003527715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.